期刊文献+

脓毒症液体复苏终点指标研究与限制性液体管理 被引量:9

Study of fluid resuscitation endpoint and restrictive fluid management on sepsis
原文传递
导出
摘要 在《严重脓毒症及脓毒性休克管理指南》(简称"指南")中,液体复苏作为重要的治疗方案,通过循证医学证据不断完善,并在全球推广,严重脓毒症及脓毒性休克的病死率明显降低。但是,在临床实践中,由于积极的液体复苏导致液体过负荷,加重心、肺、肾等重要脏器损伤等因素的存在,导致脓毒性休克的病死率仍高达40%〔1〕。因此,对液体复苏终点的研究,成为目前脓毒症治疗领域的重点。 The fluid resuscitation is an important treatment in surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock.It has been improved by evidence based medicine,spread the world,and has decreased the mortality of severe sepsis and septic shock patients.However,in clinical practice,aggressive fluid resuscitation leads to fluid overload,increases the important organs' damage,such as heart,lung,kidney,et al,so that the mortality of septic shock is still as high as 40%〔1〕.Therefore,the research on fluid resuscitation endpoint,becomes the focus of the field in the treatment of sepsis.
出处 《临床急诊杂志》 CAS 2015年第2期160-164,共5页 Journal of Clinical Emergency
关键词 脓毒症 液体复苏 终点指标 限制性液体管理 sepsis fluid resuscitation endpoint restrictive fluid management
  • 相关文献

参考文献4

二级参考文献80

  • 1刘松桥,邱海波,杨毅,陈永铭,李家琼.胸腔内血容量指数对失血性休克犬容量状态评价的意义[J].外科理论与实践,2006,11(1):24-27. 被引量:14
  • 2Rivers EP, Kruse JA, Jacobsen G, et al. The influence of early hemodynamie optimization on biomarker patterns of severe sepsis and septic shock [ J]. Crit Care Med, 2007,35 (9) : 2016- 2024.
  • 3Dellinger RP, Levy MM, Cadet JM, et ol. Surviving Sepsis Cam-paign: international guidelines for management of severe sepsis and septie shock[J]. Crit Care Med, 2008,36(1) :296-327.
  • 4Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sep- sis Campaign: results of an international guideline-based perform- ance improvement program targeting severe sepsis [ J ]. Intensive Care Med, 2010,36(2) :222-231.
  • 5Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock [ J ]. Crit Care Med, 2006,34(6) :1589-1596.
  • 6Kern JW, Shoemaker WC. Meta-analysis of hemodynamic optimi- zation in high-risk patients [ J ]. Crit Care Med, 2002,30 ( 8 ) : 1686-1692.
  • 7Jones AE, Brown MD, Trzeeiak S, et al. The effect of a quanti- tative resuscitation strategy on mortality in patients with sepsis: a meta-analysis[ J]. Crit Care Med, 2008,36(10) :2734-2739.
  • 8Kula R, Szturz P, Sklienka P, et al. A role for negative fluid balance in septic patients with abdominal compartment syndrome [ J]. Intensive Care Med,2004,30( 11 ) :2138-2139.
  • 9Murphy CV, Schramm GE, Doherty JA, et al. The importance of fluid management in acute lung injury secondary to septic shock [ J ]. Chest, 2009,136 ( 1 ) : 102 -109.
  • 10Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury[ J]. N Engl J Med, 2006,354(24) :2564-2575.

共引文献66

同被引文献74

  • 1王新颖,李维勤,李宁,黎介寿.内毒素抑制肝细胞白蛋白表达的分子机制研究[J].中国危重病急救医学,2004,16(10):626-628. 被引量:35
  • 2王红旗,魏燕玲,夏光明.气单胞菌败血症2例报告[J].中国人兽共患病杂志,1995,11(5):64-64. 被引量:2
  • 3朱红,牛红喜,何春涤.嗜水气单胞菌性面部蜂窝织炎死亡1例[J].中国麻风皮肤病杂志,2006,22(8):703-704. 被引量:4
  • 4杨守明,王民生.嗜水气单胞菌及其对人的致病性[J].疾病控制杂志,2006,10(5):511-514. 被引量:86
  • 5Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care [J]. Crit Care Med, 2001, 29 (7): 1303- 1310. DOI: 10.1097/00003246-200107000-00002.
  • 6Kumar G, Kumar N, Taneja A, et al. Nationwide trends of severe sepsis in the 21st century (2000-2007) [J]. Chest, 2011, 140 (5): 1223-1231. DOI: 10.1378/chest.11-0352.
  • 7Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units [J]. JAMA, 2009, 302 (21): 2323-2329. DOI: lO.1001/jama.2009.1754.
  • 8Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis [J]. Intensive Care Med, 2010, 36 (2): 222-231. DOI: 10.1007/s00134-009-1738-3.
  • 9Vladimirova SG, Tarasova LN, Olu S, et al. C-reactive protein as a marker of the severity of an infectious process in acute myeloid leukemia patients with neutropenia [J]. Ter Arkh, 2013, 85 (11): 34-40. DOI: 10.1016/j.surg.2014.09.009.
  • 10P6voa P, Coelho L, Almeida E, et al. Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection [J]. Clin Infect Dis, 2005, 40 (12): 1855-1857. DOI: 10.1086/430382.

引证文献9

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部